The treatment is usually given over multiple sessions, each lasting 2030 minutes
Dose reduction considerations: If a patient cannot tolerate 2.4 mg, maintaining at 1.7 mg is acceptable and still produces clinically meaningful weight loss
UHCs 2026 commercial formulary includes six GLP-1 medications: Wegovy (semaglutide for obesity and CVD), Zepbound (tirzepatide for obesity and OSA), Ozempic (semaglutide for type 2 diabetes), Mounjaro (tirzepatide for type 2 diabetes), Saxenda (liraglutide for obesity), and Rybelsus (oral semaglutide for type 2 diabetes)
One of the best things about grabbing a smoothie from Smoothie King, identifiable by their iconic crown logo, is the convenience
This includes: Nutrition guidance A dose-escalation schedule to minimize side effects Lifestyle recommendations, including activity and behavior strategies Step 5: Ongoing Monitoring Regular follow-ups allow your provider to adjust dosing, track progress, and manage any side effects
GLP-1 medications will shrink your appetite and your waistline, and without the right plan, they'll take your muscle with them
